- Home
- SRZN
SRZN
Surrozen Inc.
as 11-21-2025 3:46pm EST
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 117.8M | IPO Year: | N/A |
| Target Price: | $38.50 | AVG Volume (30 days): | 92.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.90 - $18.17 | Next Earning Date: | 11-07-2025 |
| Revenue: | $3,604,000 | Revenue Growth: | -63.96% |
| Revenue Growth (this year): | -71.44% | Revenue Growth (next year): | N/A |
Latest Surrozen Inc. News
SRZN Breaking Stock News: Dive into SRZN Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
17 days ago
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
19 days ago
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
3 months ago
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
6 months ago
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
GlobeNewswire
6 months ago
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
8 months ago
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewswire
8 months ago
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
Compare SRZN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRZN Surrozen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.